Page last updated: 2024-10-16

carnitine and Polymyositis

carnitine has been researched along with Polymyositis in 1 studies

Polymyositis: Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cui, L1
Tang, X1
Zhang, Q1
Li, B1
Du, H1
Guo, Y1

Other Studies

1 other study available for carnitine and Polymyositis

ArticleYear
EMG study in the diagnosis and differential diagnosis of lipid storage myopathy.
    Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 1998, Volume: 13, Issue:1

    Topics: Adolescent; Adult; Carnitine; Carnitine O-Palmitoyltransferase; Child; Child, Preschool; Dermatomyos

1998